8-bromo-7-methoxychrysin inhibits properties of liver cancer stem cells via downregulation of β-catenin

Figure 2 Effects of 8-bromo-7-methoxychrysin on cell proliferation and self-renewal. 8-bromo-7-methoxychrysin (BrMC) inhibited proliferation (A), self-renewal (B and C) of liver cancer stem cells derived from MHCC97 cell line (mean ± SD, n = 3). ^aP < 0.05 vs unsorted MHCC97 cells treated with corresponding concentrations of BrMC. ^cP < 0.05 vs corresponding 0.1% DMSO treated group. Tumor sphere morphology is shown as the phase contrast image (400 × magnification).